Back to AUPH
GOLDMAN SACHS GROUP INC → AUPH
GOLDMAN SACHS GROUP INC AUPH Position History
Aurinia Pharmaceuticals Inc. • Healthcare
Quarters held
16
Latest value
$887K
Q2 2026
Peak value
$82M
First seen
Q1 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q1 2025 | $5.4M |
| Q1 2025 | $7.6M |
| Q1 2025 | $109K |
| Q2 2025 | $1.5M |
| Q2 2025 | $2.2M |
| Q3 2025 | $5.2M |
| Q3 2025 | $4.1M |
| Q4 2025 | $12.3M |
| Q4 2025 | $3.8M |
| Q4 2025 | $3.8M |
| Q4 2025 | $12.3M |
| Q1 2026 | $9.6M |
| Q1 2026 | $11.7M |
| Q2 2026 | $12.5M |
| Q2 2026 | $82M |
| Q2 2026 | $887K |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q2 2026 | $887K | 52.2K | — | — |
| Q2 2026 | $82M | 4.83M | — | — |
| Q2 2026 | $12.5M | 734.5K | — | — |
| Q1 2026 | $11.7M | 788.0K | — | — |
| Q1 2026 | $9.6M | 645.5K | — | — |
| Q4 2025 | $12.3M | 769.1K | — | — |
| Q4 2025 | $3.8M | 237.2K | — | — |
| Q4 2025 | $3.8M | 237.2K | — | — |
| Q4 2025 | $12.3M | 769.1K | — | — |
| Q3 2025 | $4.1M | 373.4K | — | — |
| Q3 2025 | $5.2M | 468.7K | — | — |
| Q2 2025 | $2.2M | 265.2K | — | — |
| Q2 2025 | $1.5M | 173.8K | — | — |
| Q1 2025 | $109K | 13.6K | — | — |
| Q1 2025 | $7.6M | 947.7K | — | — |
| Q1 2025 | $5.4M | 670.3K | — | — |
Other funds holding AUPH
$53.3M
$43.9M
$43.9M
$39.9M
$37.5M